Development of a Peptide Inhibitor of Hyaluronan-mediated Leukocyte Trafficking

doi:10.1084/jem.192.6.769

Published online 11 September 2000.

This Article

	Full Text
	Full Text (PDF, 204K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Mummert, M. E.
	Articles by Takashima, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Mummert, M. E.
	Articles by Takashima, A.


Social Bookmarking

	What's this?

© The Rockefeller University Press, 0022-1007/2000/9/769/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 6, September 18, 2000 769-780

Original Article

Development of a Peptide Inhibitor of Hyaluronan-mediated Leukocyte Trafficking

Mark E. Mummert^a, Mansour Mohamadzadeh^a, Diana I. Mummert^a, Norikatsu Mizumoto^a, and Akira Takashima^a
^a Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9069

Correspondence to: Akira Takashima, Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9069. Tel:214-648-3419 Fax:214-648-3472 E-mail:atakas{at}mednet.swmed.edu.

Hyaluronan (HA), a high molecular weight glycosaminoglycan,is expressed abundantly in the extracellular matrix and on cellsurfaces. Although HA is known to bind many adhesion molecules,little information has been available with respect to its directphysiological role. In this study, we developed a novel 12-mer(GAHWQFNALTVR) peptide inhibitor of HA, termed "Pep-1," by usingphage display technology. Pep-1 showed specific binding to soluble,immobilized, and cell-associated forms of HA, and it inhibitedleukocyte adhesion to HA substrates almost completely. Systemic,local, or topical administration of Pep-1 inhibited the expressionof contact hypersensitivity responses in mice by blocking skin-directedhoming of inflammatory leukocytes. Pep-1 also inhibited thesensitization phase by blocking hapten-triggered migration ofLangerhans cells from the epidermis. These observations documentthat HA plays an essential role in "two-way" trafficking ofleukocytes to and from an inflamed tissue, and thus providetechnical and conceptual bases for testing the potential efficacyof HA inhibitors (e.g., Pep-1) for inflammatory disorders.

Key Words: glycosaminoglycan, leukocyte homing, contact hypersensitivity,Langerhans cell, phage display

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., Zheng, L. (2009). Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. JEM 206: 1327-1337 [Abstract] [Full Text]
Morioka, Y., Yamasaki, K., Leung, D., Gallo, R. L. (2008). Cathelicidin Antimicrobial Peptides Inhibit Hyaluronan-Induced Cytokine Release and Modulate Chronic Allergic Dermatitis. J. Immunol. 181: 3915-3922 [Abstract] [Full Text]
Martin, S. F., Dudda, J. C., Bachtanian, E., Lembo, A., Liller, S., Durr, C., Heimesaat, M. M., Bereswill, S., Fejer, G., Vassileva, R., Jakob, T., Freudenberg, N., Termeer, C. C., Johner, C., Galanos, C., Freudenberg, M. A. (2008). Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. JEM 205: 2151-2162 [Abstract] [Full Text]
Shimada, M., Yanai, Y., Okazaki, T., Noma, N., Kawashima, I., Mori, T., Richards, J. S. (2008). Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 135: 2001-2011 [Abstract] [Full Text]
Gao, F., Koenitzer, J. R., Tobolewski, J. M., Jiang, D., Liang, J., Noble, P. W., Oury, T. D. (2008). Extracellular Superoxide Dismutase Inhibits Inflammation by Preventing Oxidative Fragmentation of Hyaluronan. J. Biol. Chem. 283: 6058-6066 [Abstract] [Full Text]
Mahaffey, C. L., Mummert, M. E. (2007). Hyaluronan Synthesis Is Required for IL-2-Mediated T Cell Proliferation. J. Immunol. 179: 8191-8199 [Abstract] [Full Text]
Guan, H., Nagarkatti, P. S., Nagarkatti, M. (2007). Blockade of Hyaluronan Inhibits IL-2-Induced Vascular Leak Syndrome and Maintains Effectiveness of IL-2 Treatment for Metastatic Melanoma. J. Immunol. 179: 3715-3723 [Abstract] [Full Text]
Bollyky, P. L., Lord, J. D., Masewicz, S. A., Evanko, S. P., Buckner, J. H., Wight, T. N., Nepom, G. T. (2007). Cutting Edge: High Molecular Weight Hyaluronan Promotes the Suppressive Effects of CD4+CD25+ Regulatory T Cells. J. Immunol. 179: 744-747 [Abstract] [Full Text]
Kuang, D.-M., Wu, Y., Chen, N., Cheng, J., Zhuang, S.-M., Zheng, L. (2007). Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110: 587-595 [Abstract] [Full Text]
Taylor, K. R., Yamasaki, K., Radek, K. A., Nardo, A. D., Goodarzi, H., Golenbock, D., Beutler, B., Gallo, R. L. (2007). Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2. J. Biol. Chem. 282: 18265-18275 [Abstract] [Full Text]
Zaleski, K. J., Kolodka, T., Cywes-Bentley, C., McLoughlin, R. M., Delaney, M. L., Charlton, B. T., Johnson, W., Tzianabos, A. O. (2006). Hyaluronic Acid Binding Peptides Prevent Experimental Staphylococcal Wound Infection. Antimicrob. Agents Chemother. 50: 3856-3860 [Abstract] [Full Text]
Zaman, A., Cui, Z., Foley, J. P., Zhao, H., Grimm, P. C., DeLisser, H. M., Savani, R. C. (2005). Expression and Role of the Hyaluronan Receptor RHAMM in Inflammation after Bleomycin Injury. Am. J. Respir. Cell Mol. Bio. 33: 447-454 [Abstract] [Full Text]
Zmolik, J. M., Mummert, M. E. (2005). Pep-1 as a Novel Probe for the In Situ Detection of Hyaluronan. J. Histochem. Cytochem. 53: 745-751 [Abstract] [Full Text]
Dentener, M A, Vernooy, J H J, Hendriks, S, Wouters, E F M (2005). Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 60: 114-119 [Abstract] [Full Text]
Curiel, T. J., Morris, C., Brumlik, M., Landry, S. J., Finstad, K., Nelson, A., Joshi, V., Hawkins, C., Alarez, X., Lackner, A., Mohamadzadeh, M. (2004). Peptides Identified through Phage Display Direct Immunogenic Antigen to Dendritic Cells. J. Immunol. 172: 7425-7431 [Abstract] [Full Text]
Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C., Gallo, R. L. (2004). Hyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4. J. Biol. Chem. 279: 17079-17084 [Abstract] [Full Text]
Milinkovic, M., Antin, J. H., Hergrueter, C. A., Underhill, C. B., Sackstein, R. (2004). CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD. Blood 103: 740-742 [Abstract] [Full Text]
Guan, H., Zu, G., Xie, Y., Tang, H., Johnson, M., Xu, X., Kevil, C., Xiong, W.-C., Elmets, C., Rao, Y., Wu, J. Y., Xu, H. (2003). Neuronal Repellent Slit2 Inhibits Dendritic Cell Migration and the Development of Immune Responses. J. Immunol. 171: 6519-6526 [Abstract] [Full Text]
Xu, X.-M., Chen, Y., Chen, J., Yang, S., Gao, F., Underhill, C. B., Creswell, K., Zhang, L. (2003). A Peptide with Three Hyaluronan Binding Motifs Inhibits Tumor Growth and Induces Apoptosis. Cancer Res. 63: 5685-5690 [Abstract] [Full Text]
Matsue, H., Edelbaum, D., Shalhevet, D., Mizumoto, N., Yang, C., Mummert, M. E., Oeda, J., Masayasu, H., Takashima, A. (2003). Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation. J. Immunol. 171: 3010-3018 [Abstract] [Full Text]
Mummert, M. E., Mummert, D. I., Ellinger, L., Takashima, A. (2003). Functional Roles of Hyaluronan in B16-F10 Melanoma Growth and Experimental Metastasis in Mice. Molecular Cancer Therapeutics 2: 295-300 [Abstract] [Full Text]
Usui, T., Murai, T., Tanaka, T., Yamaguchi, K., Nagakubo, D., Lee, C. M., Kiyomi, M., Tamura, S., Matsuzawa, Y., Miyasaka, M. (2002). Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol 14: 1273-1282 [Abstract] [Full Text]
Mummert, M. E., Mummert, D., Edelbaum, D., Hui, F., Matsue, H., Takashima, A. (2002). Synthesis and Surface Expression of Hyaluronan by Dendritic Cells and Its Potential Role in Antigen Presentation. J. Immunol. 169: 4322-4331 [Abstract] [Full Text]
Spessotto, P., Rossi, F. M., Degan, M., Di Francia, R., Perris, R., Colombatti, A., Gattei, V. (2002). Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. JCB 158: 1133-1144 [Abstract] [Full Text]
Bardos, T., Kamath, R. V., Mikecz, K., Glant, T. T. (2001). Anti-Inflammatory and Chondroprotective Effect of TSG-6 (Tumor Necrosis Factor-{alpha}-Stimulated Gene-6) in Murine Models of Experimental Arthritis. Am. J. Pathol. 159: 1711-1721 [Abstract] [Full Text]